Rocco Sciarrillo

Department of Pediatric Oncology/Hematology,
Department of Hematology,
Department of Medical Oncology

VU University medical center

BIOGRAPHY

Rocco Sciarrillo has not added Biography.

If you are Rocco Sciarrillo and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.

European journal of medicinal chemistry Nov, 2011 | Pubmed ID: 21944286

Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.

Nature biotechnology Apr, 2014 | Pubmed ID: 24633243

Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cells.

Current drug targets , 2014 | Pubmed ID: 25483224

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.

Oncotarget Dec, 2015 | Pubmed ID: 26015408

The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia.

Haematologica Jul, 2016 | Pubmed ID: 27036162

INSTITUTIONS

VU University medical center

JOVE ARTICLES

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Rocco Sciarrillo^1,2,3,

Anna Wojtuszkiewicz¹,

Irsan E. Kooi⁴,

Valentina E. Gómez³,

Ugo Boggi⁵,

Gerrit Jansen⁶,

Gert-Jan Kaspers^1,7,

Jacqueline Cloos^*,1,

Elisa Giovannetti^*,3,8,9

¹Department of Pediatric Oncology/Hematology, VU University Medical Center,

²Department of Hematology, VU University Medical Center,

³Department of Medical Oncology, VU University Medical Center,

⁴Department of Clinical Genetics, VU University Medical Center,

⁵Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa,

⁶Amsterdam Immunology and Rheumatology Center, VU University Medical Center,

⁷, Princess Máxima Center for Pediatric Oncology,

⁸Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa,

⁹Institute of Nanoscience and Nanotechnology, CNR-Nano

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog

Rocco Sciarrillo

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Pediatric Oncology/Hematology,Department of Hematology,Department of Medical Oncology

VU University medical center

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Department of Pediatric Oncology/Hematology,
Department of Hematology,
Department of Medical Oncology